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Results: We enrolled 21 eyes of 19 patients with the diagno-
sis of Fuch’s Heterochromic Iridocyclitis who completed a
minimum of 6 months follow up. The mean follow up was
25  13.35 (range 6–48) months. Males predominated (13/
19, 68.3%). Majority (17/19, 89.5%) had unilateral presen-
tation. The age at presentation was 36.2  11 (range 18–59)
years. 31.6% (6/19) showed heterochromia. All patients
(100%) showed fine stellate filamentary keratic precipitates
and majority (57.9%) showed mild (<1/2 cells and <1/2
flare) anterior chamber inflammation. Iris atrophy was seen
in majority (15/19, 78.9%) of patients. All (100%) showed
fine vitreous cells and vitreous debris. In majority of
patients (15/19, 78.9%) Iris nodules were absent. Koeppe
nodules were seen in 15.8% (3/19) patients. Peripheral ante-
rior synechiae was noted in 3 (15.8%) patients and 2 of
them had elevated intraocular pressure which responded
to anti glaucoma treatment. All patients had developed
cataracts. Best corrected visual acuity was better than 0.5
in 12/19 (63.2%) of patients at the final follow up.
Conclusion: Our patients had less heterochromia and Iris
nodules. Subtle iris atrophy with fine keratic precipitates
and very mild anterior chamber inflammation (<1/2 cells,
<1/2 flare) along with fine vitreous cells and debris could
lead to the diagnosis of Fuch’s Heterochromic Iridocyclitis
in our population.
Keywords: Fuch’s Heterochromic Iridocyclitis; Saudi popula-
tion; Uveitis
 2014 Taibah University. Production and hosting by Elsevier
Ltd. All rights reserved.
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Fuchs’ Heterochromic Iridocyclitis (FHI) is a chronic-low
grade anterior uveitis characterized by iris heterochromia
The uveitis usually occurs with few ocular symptoms and no
related to any systemic disease.
The diagnosis of FHI is based on the criteria of Kimur
et al.1 which includes small, white, diffuse stellate keratic pre
cipitates on the corneal endothelium, mild anterior chambe
cells and flare, lack of irido-capsular posterior synechiae, vitre
ous disorders such as floaters, vitreous debris, and vitreou
cells (63–88% of cases), glaucoma (9–59% of cases), and iri
atrophy with or without heterochromia. Previous studies hav
suggested variations in the clinical spectrum of FHI in differ
ent populations.2–5
The etiology of FHI remains elusive. Ernst Fuchs, who
firstly described this disease in 1906, assumed that this syn
drome was caused by a noxious factor of unknown origin.
Since then, many theories (genetic, sympathetic, Immunologi
cal, vascular theories) and associations with toxoplasma wer
proposed. Recent studies have shown evidence for viral (rubel
la) etiology in at least some cases of FHI.9–11 Vaccination pro
grams and variable sero-prevalence of infections in differen
populations have been suggested to affect disease prevalenc
and expression.8 Comparison of clinical patterns may hav.
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implications for future studies that investigate etiology of
FHI in different population.
The purpose of the present study was to report the clinical
features of FHI in our part of the world.
Materials and Methods
Retrospective review of the clinical records of the patients with
FHI who attended the Uveitis clinic of Magrabi Eye and Ear
Hospital, Jeddah, between 2001 and 2011 was done. The diag-
nosis of FHI was based on the clinical criteria of Kimura.1
Other causes of infectious or non infectious uveitis were ex-
cluded in our patients. Diagnostic investigations including C
Reactive Protein (CRP), erythrocyte sedimentation rate, com-
plete blood count, tuberculin skin testing, chest radiography,
angiotensin-converting enzyme assay, syphilis serology
(VDRL and TPHA), and Human Leukocyte Antigen B27
(HLA B27) were ordered. For all cases a detailed medical
and ocular history were obtained.
At the initial visit, every patient was checked for best-corrected
visual acuity (VA), slit-lamp biomicroscopy, goldmann applana-
tion tonometry, indirect ophthalmoscopy, and gonioscopy. The
ora serrata and peripheral retina were examined to rule out snow
banking in eyeswith significant vitreous inflammation.Fluorescein
angiography (FA) was performed in selected cases to exclude the
possibilities of retinal vasculitis and macular edema.
Results
We found 25 patients of FHI among 587 patients who
attended our uveitis clinic in Magrabi Eye and Ear Hospital.
Among them, we included 19 patients who completed at least
6 months follow up. We had 13 (68.3%) males and 6 (31.6%)
females. Unilateral affection was present in 17 (89.5%)
patients and bilateral in two (10.5%) cases. The mean follow
up was 25 13.35 (range 6–48) months.
The age of the patients at the time of presentation varied from
18 to 59 years with a mean of 36.2 11 years. Heterochromia was
present in 6 (31.6%) patients. Posterior subcapsular cortical cat-
aract was present in all patients (100%). Anterior chamber
examination showed fine keratic precipitates (KPs) and <+1/
2 cells and<1/2 flare in all the patients (100%). Peripheral ante-
rior synechiae (PAS) was present in 3 (15.8%) patients and 2
(10.5%) of themhad elevated pressure that requiredmedications
and were controlled. No retinal lesions or any scars of old
toxoplasmosis were seen in any of our patients, while fine
vitreous cells or debris was seen in all patients (100%).
A clinical diagnosis of FHI was made or confirmed at the
initial visit by uveitis specialist (author). The most frequent
presenting symptom was visual blurring (100%). Six patients
(31.6%) were aware of the presence of heterochromia.
Best Corrected Visual Acuity (BCVA) at the last follow up
was 0.5 or better in 12 patients (63.2%), and less than 0.1 in 7
eyes (36.81%). Causes of diminished BCVA were cataract in
all cases. Ten (52.6%) patients required no medications at
the time of presentation while 9 (47.4%) patients were on top-
ical non steroidal medications with or without combined top-
ical steroids antibiotics eye drops. Ocular findings are shown in
Table 1 and Figure 1.
Discussion
The FHI is a relatively rare condition. The prevalence of FHI
in uveitis population varies from 1.2% to 4.5% in various pub-
lished studies. Recently, we found out 4.3% of prevalence of
FHI among total uveitis cases and 7.4% among anterior uve-
itis cases.12 Other studies from Saudi Arabia also reported the
prevalence that varies from 2% to 4%.13–15
The mean age in our series was 36.2 years. In other series
the mean age was from 29.5 to 40.2–5
The FHI is usually unilateral. In our study majority 17/19
(89.4%) patients had unilateral uveitis.
The KPs in FHI have been classically described as having a
stellate morphology with fibrillary extensions2–5. Small and
medium-sized round non pigmented KPs were more common
in our study. Chee and Jap7 reported the occurrence of med-
ium sized nodular endothelial deposits in eyes with FHI that
had cytomegalovirus (CMV) antigen in the aqueous humor
compared to eyes with CMV-negative FHI (60% vs 9.5%).
They postulated that CMV-infected endothelial cells might
be responsible for the nodular endothelial lesions. As aqueous
humor analysis was not done in our study, this data could not
be confirmed.
Heterochromia was absent in majority (13/19, 68%) of our
patients. Heterochromia is reported to be less common in FHI
patients with dark brown eyes.2–5 All of our patients had
brown eyes.
Detection of subtle changes on the surface of the iris, i.e.,
blunting of crypts, is more helpful for the diagnosis of FUS
in dark irides. We also found subtle blunting of iris crypts in
all our patients. Rothova and associates16 suggested that the
presence of unilateral multiple iris nodules without the forma-
tion of synechiae or heterochromia might be important for the
diagnosis of FHI, especially in dark iris. Iris nodules were ab-
sent in majority (15/19, 78.9%) of our patients. Koeppe nod-
ules were more frequently seen than Busacca nodules in our
study, consistent with previous reports.2,5 Jones17 suggested
that iris nodules were most often found in eyes without iris
atrophy or cataract during the early stages of the disease.
Majority of our patients (15/19, 79%) had iris atrophy. In
our study, we observed iris nodules in eyes with either cataract
or pseudophakia.
The presence of diffuse vitreous cells and debris adherent to
the vitreous fibrils often lead to a misdiagnosis in patients with
FHI. The presence of a healthy foveal reflex and the absence of
other inflammatory findings in the fundus should alert clini-
cians to search for FHI in patients with uveitis. In this series,
vitreous cells and fine debris were present in all (100%)
patients.
Cataract is the most common complication of FHI. The
estimated risk of cataract development was 56% at 8 years in
patients who did not receive topical corticosteroids during fol-
low-up. The high prevalence of cataract at presentation implies
a longer duration of disease.2–5 In our study, cataract was pres-
ent in all cases and this could be due to the longer duration of
the disease. Al Mansour et al.,18 recently found out that, a
shorter interval between onset of symptoms and presentation,
better initial visual acuity, and no glaucoma surgery was signif-
icantly associated with better final visual acuity in 166 patients
of FHI (1983–2005) in a tertiary center from the Riyadh region
of Saudi Arabia. We had lesser number of patients and lesser
follow up. In our study, majority (63%) had better than 0.5 vi-
sual acuity at the final follow up. We noted cataract in all our
patients. Two patients had glaucoma which was able to be con-
trolled by medications.
Our study suffers from the drawbacks inherent to a retro-
spective study. We have a less number of patients, but still,
the prevalence of FHI in our study is the highest (4.3%)
among the studies published from Saudi Arabia.13–15 The
aqueous fluid analysis was not done in our patients which
could have given new insights into the etiology of FHI in
our population.
In conclusion, by comparing this data with other series, it
was noted that fine keratic precipitates and subtle iris atrophy
were more common in our patients while heterochromia and
iris nodules were less frequent. Other clinical features such as
subtle iris changes and vitreous opacities in the absence of
macular edema were more often useful clues to the diagnosis
than heterochromia in Saudi population. The risk of cataract
development was much higher than the risk of glaucoma in pa-
tients who were not exposed to the side effects of corticoste-
roids. Analysis of aqueous humor in future studies may
reveal whether Rubella virus or CMV or another causative
Table 1: Clinical characteristics of patients presented with Fuch’s
heterochromia Iridocyclitis.
No. %
Sex
Female 6 31.6
Male 13 68.4
Age
Range 18–59 years
Mean 36.32
SD 11.828
OD/OS
OD 7 36.8
OS 10 52.6
OU 2 10.5
Heterochromia
Absent 13 68.4
Present 6 31.6
Iris atrophy
Absent 4 21.1
Present 15 78.9
Iris nodules
Absent 15 78.9
Busaca 1 5.3
Koeppe 3 15.8
Stellate KPs
Present with filaments 19 100.0
AC reaction
+1 cells and flare 1 5.3
+1/2 cells and flare 11 57.9
+2 cells and flare 1 5.3
Occasional cells and flare 3 15.8
Rare cells and flares 3 15.8
Iris vessels
Absent 12 63.2
Present 7 36.8
Angle vessels and PAS
Absent 16 84.2
Present 3 15.8
Cataract 19 100
Vitreous cells and debris 19 100
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agent is predominantly responsible for FHI in Saudi patients
and may explain the variable clinical characteristics in this
study.
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Figure 1: Presentation of clinical signs in patients with Fuch’s heterochromia uveitis.
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